stage III mantle cell lymphoma
Showing 9951 - 9975 of >10,000
Analysis of Lipids in Human Milk at Different Gestational Ages
Recruiting
- Breast Milk Collection
- Breastfeeding
-
Salerno, Naples, Italy
- +1 more
Aug 13, 2023
Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &
Active, not recruiting
- Thymoma
- +2 more
- Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
-
Duarte, California
- +7 more
May 27, 2022
Advanced Cancer Trial in Worldwide (BMS-986148, Nivolumab)
Immunotherapy, Head and Neck Tumors Trial in Amsterdam (Nivolumab, Ipilimumab)
Completed
- Immunotherapy
- Head and Neck Neoplasms
-
Amsterdam, Noord-Holland, NetherlandsNKI-AVL
Feb 12, 2021
Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)
Not yet recruiting
- Hypopharyngeal Cancer
- Cisplatin/Nedaplatin, albumin paclitaxel
- (no location specified)
May 5, 2023
Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)
Completed
- Metastatic Melanoma
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022
LONGitudinal Multi-omics Phenotyping of KIDney Function
Not yet recruiting
- Chronic Kidney Diseases
-
Berlin, GermanyExperimental and Clinical Research Center
Oct 4, 2022
Different Methods to Measure Muscle Mass and Strength
Not yet recruiting
- Obesity, Morbid
- Ultrasonography
- Dual-energy X-ray Absorptiometry
-
Leeuwarden, Friesland, NetherlandsMedical Center Leeuwarden
Feb 7, 2023
Alcohol Use Disorder Trial (Brief Motivational Interviewing, Culturally adaptation brief motivational interviewing)
Not yet recruiting
- Alcohol Use Disorder
- Brief Motivational Interviewing
- Culturally adaptation brief motivational interviewing
- (no location specified)
Mar 23, 2023
Novel Blood-based DNA Methylation Assay in Early-stage
Enrolling by invitation
- Liver Cancer
-
Beijing, China
- +8 more
May 6, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 3, 2022
Metastatic Breast Cancer Trial in Korea, Republic of (NOV120101 (Poziotinib))
Completed
- Metastatic Breast Cancer
- NOV120101 (Poziotinib)
-
Cheongju-si, Chungcheongbuk-do, Korea, Republic of
- +6 more
Jan 5, 2022
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Trial in Worldwide (MIK665)
Completed
- Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
-
Houston, Texas
- +7 more
Jul 27, 2021
Breast Cancer Trial in East Melbourne, Seoul (Placebo, Venetoclax, Trastuzumab emtansine)
Terminated
- Breast Cancer
- Placebo
- +2 more
-
East Melbourne, Victoria, Australia
- +2 more
Oct 8, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Haematopoietic Stem Cell Transplant, Autologous Trial in Melbourne,
Completed
- Acute Myeloid Leukemia
- +4 more
- FDG-PET/CT
- Conventional CT
-
Melbourne, Victoria, Australia
- +1 more
May 15, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)
Recruiting
- Nasopharyngeal Carcinoma
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022
Prostate Cancer Trial (Multiparameric MRI with injection)
Not yet recruiting
- Prostate Cancer
- Multiparameric MRI with injection
- (no location specified)
May 12, 2022
Acute Gastroenteritis, Viral Illness, Vomiting Trial in Canada (Ondansetron Oral Solution, Oral Placebo)
Recruiting
- Acute Gastroenteritis
- +3 more
- Ondansetron Oral Solution
- Oral Placebo
-
Calgary, Alberta, Canada
- +5 more
Sep 28, 2021
Fascin-1 in Colorectal Carcinoma
Recruiting
- Cancer of Colon
- Immunohistochemistry
-
Sohag, Egypt
- +1 more
Oct 30, 2022
Using Microbiome to Predict Durvalumab Toxicity in Post-
Recruiting
- NSCLC, Stage III
- Locally Advanced Lung Carcinoma
-
Kansas City, Kansas
- +1 more
May 17, 2022
Locally Advanced Cancer, Cervical Cancer Trial in France (Carboplatin-Paclitaxel adjuvant chemo)
Recruiting
- Locally Advanced Cancer
- Cervical Cancer
- Carboplatin-Paclitaxel adjuvant chemotherapy
-
Arras, France
- +5 more
Feb 17, 2022
Following Treatment With Fate Therapeutics' Engineered Cellular
Terminated
- Hematological Malignancy
- Genetically engineered NK cells
-
Phoenix, Arizona
- +4 more
Aug 24, 2022
Genetic Diversity of Toxoplasma Gondii in Cancer Patients
Recruiting
- Toxoplasma Gondii Infection
- Cancer
- ELISA
- +2 more
-
Sohag, EgyptSohag University Hospitals
Jan 12, 2022
HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)
Active, not recruiting
- HNSCC
- Cetuximab
- +3 more
-
Lorient, FranceCentre Hospitalier Bretagne Sud
Mar 10, 2022
Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T Cell Trial in Monza (Sport Therapy)
Recruiting
- Leukemia, Myeloid, Acute
- +7 more
- Sport Therapy
-
Monza, MB, ItalyMaria Letizia Verga Center, Pediatric Clinic, University of Mila
Oct 24, 2022